
Sign up to save your podcasts
Or


Episode Breakdown:
00:00 – Intro
00:21 – Why materials matter in medical device design
01:14 – Dr. Upma Sharma’s path from engineer to medtech CEO
03:01 – Arsenal’s founding story with Bob Langer and George Whitesides
06:20 – DARPA’s battlefield challenge and the birth of Rescue Foam
10:15 – How “Fix-a-Flat” foam saves lives internally
11:44 – Neocast: A liquid embolic inspired by toothpaste physics
14:33 – How Arsenal removes the “art” from embolic injections
16:14 – Arsenal’s pipeline across trauma, neuro, and women’s health
19:26 – Why chronic brain bleeds may surpass stroke
22:38 – How Arsenal approaches spinouts and strategic exits
23:42 – Fundraising goals and IDE milestones
25:49 – Clinicians’ role in shaping product development
28:14 – The broader potential of Arsenal’s biomaterials platform
29:48 – First-in-human data coming to SNIS and LSI London
30:12 – Outro
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on:
Follow Omar M. Khateeb on
By State of MedtechEpisode Breakdown:
00:00 – Intro
00:21 – Why materials matter in medical device design
01:14 – Dr. Upma Sharma’s path from engineer to medtech CEO
03:01 – Arsenal’s founding story with Bob Langer and George Whitesides
06:20 – DARPA’s battlefield challenge and the birth of Rescue Foam
10:15 – How “Fix-a-Flat” foam saves lives internally
11:44 – Neocast: A liquid embolic inspired by toothpaste physics
14:33 – How Arsenal removes the “art” from embolic injections
16:14 – Arsenal’s pipeline across trauma, neuro, and women’s health
19:26 – Why chronic brain bleeds may surpass stroke
22:38 – How Arsenal approaches spinouts and strategic exits
23:42 – Fundraising goals and IDE milestones
25:49 – Clinicians’ role in shaping product development
28:14 – The broader potential of Arsenal’s biomaterials platform
29:48 – First-in-human data coming to SNIS and LSI London
30:12 – Outro
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on:
Follow Omar M. Khateeb on